Diagnosis and treatment of acquired haemophilia
Authors:
- 23 April 2010
- journal article
- Published by Wiley in Haemophilia
- Vol. 16 (102) , 102-106
Abstract
Summary. Acquired haemophilia (AH) is an autoimmune syndrome characterized by acute bleeding in patients with negative family and personal history, and factor VIII depletion. Its incidence is 1.6 × 106 population per year. AH is associated with autoimmune diseases, solid tumours, lymphoprolipherative diseases, pregnancy; 50% of the cases idiopathic. Spontaneous or after minor trauma severe bleeding associated with a prolonged activated partial thromboplastin time, not corrected by incubation with normal plasma, with a normal prothrombin time are the diagnostic hallmarks. The goals of management are the control of bleeding and the suppression of inhibitor. First‐line haemostatic treatment includes recombinant factor VIIa and activated prothrombin complex concentrate. Prednisone ± cyclophosphamide and other immunosuppressive agents are the standard intervention for inhibitor eradication.Keywords
This publication has 20 references indexed in Scilit:
- Recombinant Factor VIIa (Eptacog Alfa)BioDrugs, 2008
- Factor VIII inhibitor bypassing activity (FEIBA) – addressing safety issuesHaemophilia, 2007
- Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisalHaemophilia, 2007
- Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' OrganisationBlood, 2006
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors OrganisationBritish Journal of Haematology, 2006
- Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIaJAMA, 2006
- Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo immunomodulating conceptBlood, 2005
- The use of recombinant factor VIIa in the treatment of bleeding disordersBlood, 2004
- Cytotoxic suppression of acquired factor VIII:C inhibitorsThe American Journal of Medicine, 1991
- Acquired HemophiliaArchives of internal medicine (1960), 1987